LYMPHOBLASTIC LYMPHOMA
Clinical trials for LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One cord blood unit may replace two in stem cell transplants for blood cancer
Disease control CompletedThis study tested a new way to treat blood cancers like leukemia in 16 adults who did not have a standard bone marrow donor. Doctors used a single unit of cord blood that was grown in a lab to increase the number of stem cells before transplant. The goal was to see if this method…
Matched conditions: LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Selective immune cell removal may tame transplant complications
Disease control CompletedThis study tested whether removing a specific type of immune cell (naïve T cells) from donor stem cell grafts could prevent graft-versus-host disease (GVHD) after a stem cell transplant for blood cancers. The trial enrolled 84 patients who received high- or medium-intensity chemo…
Matched conditions: LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Tailored combo therapy boosts leukemia fight in adults
Disease control CompletedThis study tested a personalized, intensive treatment plan for adults aged 18-55 with newly diagnosed acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma. The approach used strong chemotherapy, targeted drugs like nelarabine for T-cell ALL, and risk-based stem cell trans…
Matched conditions: LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: Goethe University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Experimental liposomal chemo shows promise in kids with relapsed leukemia
Disease control CompletedThis pilot study tested a liposomal form of the chemotherapy drug vincristine (Marqibo) combined with standard UK ALL R3 chemotherapy in 29 children, adolescents, and young adults with relapsed acute lymphoblastic leukemia. The main goal was to see if it was safe and tolerable at…
Matched conditions: LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Therapeutic Advances in Childhood Leukemia Consortium • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Donor CAR-T cells take on aggressive t-cell leukemia in early trial
Disease control CompletedThis early-phase study tested a new treatment called WU-CART-007 for people with T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma that came back or didn't respond to standard therapy. The treatment uses immune cells from a healthy donor that are specially designed to…
Matched conditions: LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Wugen, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Can a fitness tracker and coaching get teens with leukemia moving?
Symptom relief CompletedThis study tested whether a mobile health program—including a Fitbit with movement reminders, coaching sessions, and a WhatsApp peer support group—could help 20 adolescents and young adults with acute lymphoblastic leukemia (ALL) reduce the time they spend sitting or lying down d…
Matched conditions: LYMPHOBLASTIC LYMPHOMA
Phase: NA • Sponsor: Children's Hospital Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC